Janus Henderson Group’s Ventyx Biosciences VTYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-18,074
Closed -$44.7K 2576
2023
Q4
$44.7K Sell
18,074
-1,688,710
-99% -$16M ﹤0.01% 2541
2023
Q3
$59.3M Sell
1,706,784
-59,523
-3% -$2.06M 0.04% 336
2023
Q2
$57.9M Buy
1,766,307
+167,891
+11% +$5.79M 0.04% 363
2023
Q1
$53.5M Buy
1,598,416
+134,644
+9% +$5.24M 0.04% 366
2022
Q4
$48M Buy
1,463,772
+149,233
+11% +$4.42M 0.03% 382
2022
Q3
$45.9M Sell
1,314,539
-590,708
-31% -$13.1M 0.03% 379
2022
Q2
$23.3M Sell
1,905,247
-228,607
-11% -$3.42M 0.02% 538
2022
Q1
$28.2M Sell
2,133,854
-32,678
-2% -$437K 0.01% 667
2021
Q4
$40.8M Buy
+2,166,532
New +$41.1M 0.02% 614

Other funds holding VTYX

Janus Henderson Group's VTYX Position: Q1 2024 in Review

Janus Henderson Group sold out of Ventyx Biosciences (VTYX) in Q1 2024, closing a stake of 18,074 shares — an estimated $44.7K sold.

Janus Henderson Group first reported a position in VTYX in Q4 2021 and held it in 9 quarters. The position peaked at $59.3M in Q3 2023. 126 funds tracked by Wall St. Rank hold VTYX as of Q1 2024.

  • Janus Henderson Group reported no remaining Ventyx Biosciences position as of Q1 2024 after selling out during the quarter.
  • Janus Henderson Group sold 18,074 Ventyx Biosciences shares in Q1 2024, an estimated $44.7K.
  • Janus Henderson Group first reported a position in Ventyx Biosciences in Q4 2021 and held it in 9 quarters.
  • Janus Henderson Group's Ventyx Biosciences position peaked at $59.3M in Q3 2023.
  • 126 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2024.

Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.